advertisement

WGA Rescources

Drug Delivery 11

Showing records 1 to 11 | Display all abstracts in Drug Delivery

121604 γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application
Huling J
Drug Delivery 2024; 31: 2361168
124420 Development of a novel SupraChoroidal-to-Optic-NervE (SCONE) drug delivery system
Chiang B
Drug Delivery 2024; 31: 2379369
121604 γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application
Oschatz S
Drug Delivery 2024; 31: 2361168
124420 Development of a novel SupraChoroidal-to-Optic-NervE (SCONE) drug delivery system
Heng K; Jang K
Drug Delivery 2024; 31: 2379369
121604 γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application
Lange H; Sterenczak KA
Drug Delivery 2024; 31: 2361168
124420 Development of a novel SupraChoroidal-to-Optic-NervE (SCONE) drug delivery system
Dalal R; Liao YJ
Drug Delivery 2024; 31: 2379369
121604 γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application
Stahnke T
Drug Delivery 2024; 31: 2361168
124420 Development of a novel SupraChoroidal-to-Optic-NervE (SCONE) drug delivery system
Myung D
Drug Delivery 2024; 31: 2379369
121604 γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application
Markhoff J; Stachs O
Drug Delivery 2024; 31: 2361168
124420 Development of a novel SupraChoroidal-to-Optic-NervE (SCONE) drug delivery system
Goldberg JL
Drug Delivery 2024; 31: 2379369
121604 γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application
Möller S; Undre N; Peil A; Jünemann A; Grabow N; Fuellen G; Eickner T
Drug Delivery 2024; 31: 2361168

Issue 25-1

Change Issue


advertisement

Nidek